Fuse Medical Inc (FZMD)
0.095
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Fuse Medical Gross Profit Margin (Quarterly): 69.42% for June 30, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 69.42% |
| March 31, 2023 | 70.68% |
| December 31, 2022 | 53.48% |
| September 30, 2022 | 67.34% |
| June 30, 2022 | 56.55% |
| March 31, 2022 | 61.72% |
| December 31, 2021 | 58.01% |
| September 30, 2021 | 56.20% |
| June 30, 2021 | 60.82% |
| March 31, 2021 | 58.25% |
| December 31, 2020 | 59.06% |
| September 30, 2020 | 64.39% |
| June 30, 2020 | 55.20% |
| March 31, 2020 | 57.23% |
| December 31, 2019 | 62.17% |
| September 30, 2019 | 16.24% |
| June 30, 2019 | 56.19% |
| March 31, 2019 | 58.59% |
| December 31, 2018 | 56.46% |
| September 30, 2018 | 55.08% |
| Date | Value |
|---|---|
| June 30, 2018 | 34.07% |
| March 31, 2018 | 47.98% |
| December 31, 2017 | 50.43% |
| September 30, 2017 | 45.57% |
| June 30, 2017 | 37.96% |
| March 31, 2017 | 45.25% |
| December 31, 2016 | 55.98% |
| September 30, 2016 | 60.46% |
| June 30, 2016 | 82.73% |
| March 31, 2016 | 57.87% |
| December 31, 2015 | 53.02% |
| September 30, 2015 | 62.68% |
| June 30, 2015 | 63.42% |
| March 31, 2015 | 64.43% |
| December 31, 2014 | 19.39% |
| September 30, 2014 | 64.90% |
| June 30, 2014 | 60.24% |
| March 31, 2014 | 63.59% |
| November 30, 2013 | |
| August 31, 2013 | 80.79% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
16.24%
Minimum
Sep 2019
70.68%
Maximum
Mar 2023
57.82%
Average
58.25%
Median
Mar 2021
Gross Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 10.78% |
| Xtant Medical Holdings Inc | 60.97% |
| Asensus Surgical Inc | 21.47% |
| Catheter Precision Inc | 94.53% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | 18.95% |
| Return on Invested Capital | 645.2% |
| Profit Margin (Quarterly) | 6.16% |
| Operating Margin (Quarterly) | 7.38% |
| Return on Net Operating Assets | 22.42% |